BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9447215)

  • 1. Practical considerations in the early treatment of ischemic stroke.
    Broderick JP
    Am Fam Physician; 1998 Jan; 57(1):73-80. PubMed ID: 9447215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke.
    California Acute Stroke Pilot Registry (CASPR) Investigators
    Neurology; 2005 Feb; 64(4):654-9. PubMed ID: 15728287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twelve-month experience of acute stroke thrombolysis in Christchurch, New Zealand: emergency department screening and acute stroke service treatment.
    Fink J
    N Z Med J; 2005 May; 118(1214):U1430. PubMed ID: 15886726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke: part II. Management of acute ischemic stroke.
    Benavente O; Hart RG
    Am Fam Physician; 1999 May; 59(10):2828-34 concl. PubMed ID: 10348075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved time intervals by implementation of computerized physician order entry-based stroke team approach.
    Nam HS; Han SW; Ahn SH; Lee JY; Choi HY; Park IC; Heo JH
    Cerebrovasc Dis; 2007; 23(4):289-93. PubMed ID: 17199086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic therapy for acute ischemic stroke.
    Solenski NJ
    Va Med Q; 1998; 125(2):128-30. PubMed ID: 9577716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of applied cases of thrombolytic therapy against ultra-acute ischemic stroke. Using the Japanese Standard Stroke Registry Database.
    Shiotsuki H; Ogushi Y; Fushimi K; Kobayashi S;
    Tokai J Exp Clin Med; 2005 Apr; 30(1):49-62. PubMed ID: 15952299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolytic therapy in acute ischemic stroke.
    Clark WM; Lyden PD; Madden KP; Zivin JA
    N Engl J Med; 1997 Jan; 336(1):65-6; author reply 66-7. PubMed ID: 8984333
    [No Abstract]   [Full Text] [Related]  

  • 11. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
    Cocho D; Belvís R; Martí-Fàbregas J; Molina-Porcel L; Díaz-Manera J; Aleu A; Pagonabarraga J; García-Bargo D; Mauri A; Martí-Vilalta JL
    Neurology; 2005 Feb; 64(4):719-20. PubMed ID: 15728300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's the "hyper" in hyperacute stroke? Strategies to improve outcomes in ischemic stroke patients presenting within 6 hours.
    Bader MK; Palmer S
    AACN Adv Crit Care; 2006; 17(2):194-214. PubMed ID: 16767022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke associated with thrombolytic therapy for acute myocardial infarction.
    Sloan MA
    Heart Dis Stroke; 1992; 1(5):287-94. PubMed ID: 1344119
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intravenous tissue plasminogen activator in the treatment of acute ischemic stroke: feasibility, safety, and efficiency in the 2 first years of the clinical practice].
    Feuerhake W; Chamorro H; Araya F
    Rev Med Chil; 1999 Jul; 127(7):814-9. PubMed ID: 10668289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided.
    Boode B; Welzen V; Franke C; van Oostenbrugge R
    Cerebrovasc Dis; 2007; 23(4):294-8. PubMed ID: 17199087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke treatment: beyond the three-hour window and in the pregnant patient.
    Cronin CA; Weisman CJ; Llinas RH
    Ann N Y Acad Sci; 2008 Oct; 1142():159-78. PubMed ID: 18990126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why ischemic stroke patients do not receive thrombolytic treatment: results from a general hospital.
    van den Berg JS; de Jong G
    Acta Neurol Scand; 2009 Sep; 120(3):157-60. PubMed ID: 19719807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombolytic therapy in stroke approved with reservation. Underlying evidence, practical guidelines and safety follow up].
    Wahlgren NG
    Lakartidningen; 2004 Feb; 101(8):674-7. PubMed ID: 15024940
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T; Minematsu K
    Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.